Diagnostic Center | February 21, 2023
Redcliffe Labs launches BD MAX MDR TB test for MDR-TB in a Single test
Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test
Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test
New manufacturing facility dedicated to the production of active pharmaceutical ingredients (APIs) and high potency active pharmaceutical ingredients (HPAPIs)
Cipla has received 8 inspectional observations in Form 483
There is a fast resurgence in the transplant activities post COVID
The new sterile filling line meets cGMP aseptic filling regulatory requirements
Fluor is providing architectural and engineering services and procuring equipment for the new 275,000 square-foot manufacturing facility that will house two manufacturing lines to double manufacturing capability
IAGES to focus on upskilling and adoption of advanced Minimal Access Surgery technologies in 2023
Data build on previously reported results from the primary endpoint of investigator-assessed radiographic progression-free survival
The workshop strived to sensitize states and various stakeholder departments regarding their role in the implementation of National Patient Safety Implementation Framework, as well as augment capacity building of health care professionals
Themis will market this drug with the brand name REMITHEM.
Subscribe To Our Newsletter & Stay Updated
